Related Experiment Video
Updated: Mar 20, 2026

Murine Model of Thoracic Aortic Dissection Induced by Oral β-Aminopropionitrile and Subcutaneous Angiotensin II Infusion
Published on: May 16, 2025
Exercise Attenuates Aortic Dissection Via PDE5A-Mediated Inhibition of Vascular Smooth Muscle Cell Phenotypic Switch
Yi Zhang1, Chunyan Wu2, Dongdong Du3
1Department of Cardiovascular Surgery, Tianjin Medical University General Hospital, Ministry of Education International Joint Laboratory of Ocular Diseases, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of Pharmacy, Tianjin Medical University, China (Y.Z., N.W., S.Z.).
Background:
Aortic dissection (AD) is a life-threatening condition and involves pathological vascular smooth muscle cell (VSMC) phenotypic switching from a contractile to a synthetic state. Although exercise confers broad cardiovascular benefits, its role in AD pathogenesis remains unclear. This study aimed to determine whether exercise attenuates AD by modulating VSMC phenotype and to elucidate the underlying molecular mechanism.
Methods:
Human aortic tissues from AD patients were analyzed for VSMC phenotypic markers and PDE5A (phosphodiesterase 5A) expression. A β-aminopropionitrile induced AD model was established in wild-type mice with or without treadmill exercise intervention. RNA sequencing, gain- and loss-of-function experiments, and mechanistic assays were employed to investigate the roles of PDE5A and its transcriptional regulator RUNX1 (runt-related transcription factor 1).
Results:
In human AD lesional tissues, contractile VSMC markers (MYH11 [myosin heavy chain 11], CNN1 [calponin 1], and α-SMA [alpha-smooth muscle actin]) were significantly downregulated, whereas the synthetic marker osteopontin was upregulated. In β-aminopropionitrile-induced AD mice, exercise improved survival, reduced aortic dilation and AD incidence, and preserved the contractile VSMC phenotype. RNA-seq analysis identified PDE5A as a key exercise-responsive gene. PDE5A expression was reduced in human AD lesional tissues and β-aminopropionitrile-treated mice but was upregulated by exercise. VSMC-specific overexpression of PDE5A attenuated AD progression, whereas PDE5A inhibition abolished the attenuating effects of exercise. We further identified RUNX1 as a transcriptional repressor of PDE5A that is upregulated in AD conditions and suppressed by exercise. Inhibition of RUNX1 upregulated PDE5A expression, preserved VSMC contractility, and reduced AD incidence.
Conclusions:
In conclusion, we identify a novel RUNX1-PDE5A axis that mediates the beneficial effects of exercise against AD. Exercise attenuates AD by reducing RUNX1-mediated transcriptional repression of PDE5A, thereby maintaining VSMC contractile phenotype. These findings highlight the RUNX1-PDE5A pathway as a promising preventive target.
More Related Videos
08:28Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
06:14Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
Published on: June 11, 2017
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antihypertensive Drugs: Vasodilators